AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-13269868_ITM" title="Facts and information about Good results from clinical study of Q-med's ZUIDEX.">Good results from clinical study of Q-med's ZUIDEX.</a>
Close
Set up an RSS feed that alerts you when new articles from Asia Africa Intelligence Wire are available.
Frequently asked questions about RSS feeds
Good results from clinical study of Q-med's ZUIDEX.
(From Chemical Business NewsBase - Dagens Industri)
A major 1-year European study has shown that nearly 8 out of 10 women with stress incontinence treated with Q-med's ZUIDEX experienced less discomfort and a higher quality of life after 1 year of treatment. The ZUIDEX method involves injection of a gel of hyaluronic acid and dextranomer into the urinary passage under local anaesthetic and patients are normally allowed to go home after just 2 hours. The effect is …
Related articles from newspapers, magazines, journals, and more
-
- Dagens Industri: Optimism over Astra Zeneca's Crestor.
-
News wire article from: Asia Africa Intelligence Wire
July 27, 2002
700+ words
-
- Dagens Industri: New findings on Tripep's GPG plus metabolite.
-
News wire article from: Asia Africa Intelligence Wire
July 12, 2002
700+ words
-
- Dagens Industri: Astra Zeneca not worried over Pfizer/Pharmacia deal.
-
News wire article from: Asia Africa Intelligence Wire
July 15, 2002
700+ words
-
- Dagens Industri: Astra Zeneca's Iressa has no effect in combination with...
-
News wire article from: Asia Africa Intelligence Wire
August 19, 2002
700+ words
-
- Dagens Industri: Karlshamns results up in 1H 2002.
-
News wire article from: Asia Africa Intelligence Wire
August 20, 2002
700+ words
